Guselkumab Safety in Patients With Latent Tuberculosis: Analysis of 11 Studies in Psoriatic Disease.

Saved in:
Bibliographic Details
Title: Guselkumab Safety in Patients With Latent Tuberculosis: Analysis of 11 Studies in Psoriatic Disease.
Authors: Puig L; Hospital de la Santa Creu i Santa Pau, Universitat Autònoma de Barcelona, Barcelona, Spain., Tsai TF; National Taiwan University Hospital, Taipei, Taiwan., Soriano ER; Rheumatology Section, Internal Medicine Service, Hospital Italiano de Buenos Aires, and University Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Bhutani T; Synergy Dermatology, San Francisco, California, USA., Miller M; Johnson & Johnson, Spring House, Pennsylvania, USA., Kollmeier AP; Johnson & Johnson, San Diego, California, USA., Li S; Johnson & Johnson, Spring House, Pennsylvania, USA., Li H; Johnson & Johnson, Titusville, New Jersey, USA., Ofori S; Johnson & Johnson, Horsham, Pennsylvania, USA., Pawlikowski J; Johnson & Johnson, Horsham, Pennsylvania, USA., Adamson E; Johnson & Johnson, Horsham, Pennsylvania, USA., Gooderham M; SKiN Centre for Dermatology, Department of Medicine at Queen's University, and Probity Medical Research, Peterborough, Ontario, Canada., Londoño Garcia A; CES University, Medellín, Colombia., Lebwohl M; Icahn School of Medicine at Mount Sinai, New York, New York, USA., Nash P; Griffith University School of Medicine, Brisbane, and Queensland Health, Sunshine Coast University Hospital, Brisbane, Queensland, Australia.
Source: The Journal of dermatology [J Dermatol] 2026 Jul; Vol. 53 (7), pp. 1026-1031. Date of Electronic Publication: 2026 Jun 01.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1346-8138 (Electronic) Linking ISSN: 03852407 NLM ISO Abbreviation: J Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1346-8138
DOI:10.1111/1346-8138.70314